Basel Medical Group Ltd Ordinary Shares (BMGL) vs Ernexa Therapeutics Inc. (ERNA)
A side-by-side comparison of Basel Medical Group Ltd Ordinary Shares and Ernexa Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BMGL
Basel Medical Group Ltd Ordinary Shares
$3.36HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
ERNA
Ernexa Therapeutics Inc.
$2.75HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Total return — BMGL vs ERNA
growth of $100 · dividends reinvested · last 2yBMGL -94.1% (-75.6%/yr)ERNA -98.0% (-85.7%/yr)BMGL compounded faster over this window
BMGL ERNA
BMGL vs ERNA: by the numbers
- •BMGL is the larger company ($5M vs $4M market cap).
- •Both run net losses; ERNA's is the smaller (0.00% vs -106.78% net margin).
Metrics side by side
Valuation
| Metric | BMGL | ERNA |
|---|---|---|
| P/B ratio | 1.08 | 1.40 |
Profitability
| Metric | BMGL | ERNA |
|---|---|---|
| Gross margin | 77.68% | 0.00% |
| Operating margin | -19.28% | 0.00% |
| Net margin | -106.78% | 0.00% |
| ROE | -248.66% | -383.03% |
| ROIC | -35.07% | -346.94% |
Growth (annualized)
| Metric | BMGL | ERNA |
|---|---|---|
| Total return CAGR (5Y) | N/A | -86.83% |
Go deeper
Dig into the metrics
Basel Medical Group Ltd Ordinary Shares ROEErnexa Therapeutics ROEBasel Medical Group Ltd Ordinary Shares operating marginErnexa Therapeutics operating marginBasel Medical Group Ltd Ordinary Shares revenue growthErnexa Therapeutics revenue growthBasel Medical Group Ltd Ordinary Shares free cash flowErnexa Therapeutics free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.